Selvita

Activities: Research & Development

Trending Articles

  1. LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
  2. Fasenra for EGPA: addressing unmet needs Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
  5. Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Recruitment

Selvita appoints Dr Steffen Heeger as Chief Medical Officer
Research & Development

Selvita promotes Edyta Jaworska to its management board
Research & Development

Epidarex Capital creates Nodthera Limited

A pioneering new company based on Selvita research and utilising novel immunological approaches to disease
Design & Build

Selvita opens new research site in Poznan, Poland

Will initially employ around 50 chemist and biologists
Research & Development

Merck and Selvita enter new drug discovery collaboration

With the aim of discovering small molecule lead candidates for multiple oncology indications
Finance

Selvita launches new company

Ardigen will focus on bioinformatics and personalised medicine
Research & Development

Selvita establishes UK subsidiary in Cambridge

To be closer to business partners located in the UK
Subscribe now